Work

Targeting Protein Disulfide Isomerase with the Oral Flavonoid Isoquercetin Prevents Venous Thromboembolism in Advanced Cancer: Results of a Multi-Dose, Multi-Center, Phase II Clinical Trial (CATIQ Study)

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-114946

Authors: Jeffrey I. Zwicker, Benjamin L. Schlechter, Jack Davis Stopa, Howard A. Liebman, Anita Aggarwal, Thomas Caughey, Ken A. Bauer, Nancy Kuemmerle, Ellice Y. Wong, Ted Wun, Marilyn Mclaughlin, Maneka Puligandla, Donna S Neuberg, Bruce Furie, Robert C. Flaumenhaft

Institutions: Beth Israel Deaconess Medical Center, Harvard University, University of Southern California, Veterans Health Administration, Washington DC VA Medical Center, Mount Auburn Hospital, White River Junction VA Medical Center, VA Connecticut Healthcare System, UC Davis Comprehensive Cancer Center, York Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Venous Thromboembolism Diagnosis and Management

Subfield: Internal Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2906999972

Cites:

Cited by: 1

Related to: 10